News
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai. The ...
Latest research on parenting. Everything from infancy through the teen years, including breastfeeding, colic, academic success, behavioral problems, teen relationships and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results